ETON Eton Pharmaceuticals Inc
P/E
127.38
Forward P/E
21.88
Price/Sales
13.79
Beta
0.831
Div Yield
--
Market Cap
--
Company Analysis
Latest News
Eton Pharmaceuticals Inc Q3 2026 Earnings Preview: What Analysts Expect on November 05, 2026
Eton Pharmaceuticals is expected to report Q3 2026 consensus revenue of $42.21 million and EPS of $0.34, with the stock currently trading near $50.95 against a...
Eton Pharmaceuticals Announces ET-900 Program for Epileptic Spasms with Baylor License
Eton Pharmaceuticals announced ET-900, a new development program to evaluate mecasermin injection for the treatment of infantile and epileptic spasms. The...